Although Kevin Byrne has faced many challenges due to MS, he's committed to fighting the good fight. His motto is "never stop ...

The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) and to ...

Research shows that analyzing walking patterns can detect early signs of neurological disorders, orthopedic issues, and even ...

Tolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory ...

The butcher in the WA town of Pingelly is selling up and the council is offering a significant financial incentive to whoever buys the business and keeps it running.

Ronald Harris reframed his multiple scleroris diagnosis and now imagines MS as a permanent but uninvited guest at his dinner ...

This group has a lower proportion of women, a higher proportion of primary progressive MS, a higher level of disability at diagnosis, and a higher proportion of gait-related initial symptoms than ...

Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device: Newtown, Pennsylvania Thursday, March ...